• Eligible shareholders can apply for up to A$30,000 worth of new shares
• New shares priced at A$1.94, a 16.4% discount to last trading day's closing price
• Free-attaching quoted options available on a 3-for-4 basis

EMVision Medical Devices Ltd has announced the launch of a Share Purchase Plan Offer, providing eligible shareholders the opportunity to apply for up to A$30,000 worth of new fully paid ordinary shares in the company at an issue price of A$1.94 per share. This issue price represents a 16.4% discount to the closing price of the company's shares on the last trading day immediately prior to the announcement of the offer. Eligible shareholders who apply for new shares under the offer will also be invited to subscribe for free-attaching quoted options on the basis of three options for every four new shares applied for and issued. The offer is non-renounceable and the maximum number of new shares to be issued is capped at 1,030,928, subject to a total raise of up to A$2,000,000. The company reserves the right to scale back applications at its absolute discretion. The new shares will rank equally with the company's existing shares and the company will apply for their quotation on the ASX. Funds raised from the offer will be used to advance the company through major milestones, including supporting FDA submission and initial commercialisation activities for the emuTM device, and advancing the First Responder program through clinical trials, production readiness and regulatory preparation.